İzmir Biomedicine and Genome Center Researcher's Cancer Treatment Method Receives Patent
İzmir Biomedicine and Genome Center Researcher's Cancer Treatment Method Receives Patent
Izmir Biomedicine and Genome Center (İBG) researcher Prof. Dr. Hülya Ayar Kayalı's invention titled “Polymeric nanoparticle with cytotoxic effect specifically on ovarian cancer cells and method of preparation” was patented by the Turkish Patent and Trademark Office (Application Number: 2023/004757).
Ovarian cancer is most lethal type of gynecologic cancer and is often difficult to diagnose because it does not show early symptoms. The side effects and limited effectiveness of existing treatments such as surgery, radiation, chemotherapy and immunotherapy lead to the need for new and effective treatment methods. In recent years, there has been a focus on the use of nanoparticles in cancer treatment because they have advantages such as encapsulating cytotoxic drugs, increasing their stability and improving their safety.
In the invention subject to the patent, which was carried out at the Izmir Biomedicine and Genome Center with the support of TÜSEB and DEÜ BAP, a polymeric nanoparticle that targets ovarian cancer cells and has a cytotoxic effect is defined and its preparation method is explained. The polymeric nanoparticle structures in question stand out as a special treatment method that targets and effectively inhibits ovarian cancer cells.
Izmir Biomedicine and Genome Center (İBG) researcher Prof. Dr. Hülya Ayar Kayalı's invention titled “Polymeric nanoparticle with cytotoxic effect specifically on ovarian cancer cells and method of preparation” was patented by the Turkish Patent and Trademark Office (Application Number: 2023/004757).
Ovarian cancer is most lethal type of gynecologic cancer and is often difficult to diagnose because it does not show early symptoms. The side effects and limited effectiveness of existing treatments such as surgery, radiation, chemotherapy and immunotherapy lead to the need for new and effective treatment methods. In recent years, there has been a focus on the use of nanoparticles in cancer treatment because they have advantages such as encapsulating cytotoxic drugs, increasing their stability and improving their safety.
In the invention subject to the patent, which was carried out at the Izmir Biomedicine and Genome Center with the support of TÜSEB and DEÜ BAP, a polymeric nanoparticle that targets ovarian cancer cells and has a cytotoxic effect is defined and its preparation method is explained. The polymeric nanoparticle structures in question stand out as a special treatment method that targets and effectively inhibits ovarian cancer cells.